{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29730669", "DateCompleted": {"Year": "2018", "Month": "09", "Day": "28"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "05", "Day": "06"}], "Language": ["eng"], "ELocationID": ["10.12659/MSM.906509"], "Journal": {"ISSN": "1643-3750", "JournalIssue": {"Volume": "24", "PubDate": {"Year": "2018", "Month": "May", "Day": "06"}}, "Title": "Medical science monitor : international medical journal of experimental and clinical research", "ISOAbbreviation": "Med Sci Monit"}, "ArticleTitle": "Corilagin Reduces the Frequency of Seizures and Improves Cognitive Function in a Rat Model of Chronic Epilepsy.", "Pagination": {"StartPage": "2832", "EndPage": "2840", "MedlinePgn": "2832-2840"}, "Abstract": {"AbstractText": ["BACKGROUND Worldwide, epilepsy is an important chronic neurological condition. The aim of this study was to evaluate the effects of corilagin, an ellagitannin extracted from medicinal plants, on the frequency of seizures and cognitive function in a rat model of chronic epilepsy. MATERIAL AND METHODS Chronic epilepsy was induced in male Wistar rats by intraperitoneal (IP) injection of pentylenetetrazol (PTZ) for 36 days. Corilagin, 10 mg/kg and 20 mg/kg, was injected IP into treated rats, 24 days before the start of PTZ treatment, until the end of the protocol. The effects of corilagin were assessed by the pattern of epileptic seizures; cognitive function was assessed using the Morris water maze (MWM) navigation test. The mechanism of action of corilagin was investigated by measuring cytokine levels and oxidative stress parameters, including reactive oxygen species (ROS) production, and carbonic anhydrase inhibitory (CAI) activity. Histological analysis of fixed brain tissue sections included cresyl violet acetate staining (Nissl staining) for Nissl substance in the neuronal cytoplasm. RESULTS The corilagin-treated rats, compared with the control group, showed a significantly lower rate of epileptic events, improved cognitive function, reduced level of cytokines, reduced ROS production reduced CAI activity in the brain tissues (P<0.01). Histology of the rat brain tissues study showed that corilagin treatment maintained the neuronal cellular structure and number of surviving cells compared with the control group of rats. CONCLUSIONS The findings of this study showed that corilagin reduced the frequency of seizures and improved the cognitive function in a rat model of chronic epilepsy."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology, XiangYang Central Hospital, Xiangyang, Hubei, China (mainland)."}], "LastName": "Yu", "ForeName": "Xue", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology, XiangYang Central Hospital, Xiangyang, Hubei, China (mainland)."}], "LastName": "Zhou", "ForeName": "Tao", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology, XiangYang Central Hospital, Xiangyang, Hubei, China (mainland)."}], "LastName": "Yu", "ForeName": "Heng", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology, XiangYang Central Hospital, Xiangyang, Hubei, China (mainland)."}], "LastName": "Chang", "ForeName": "Li-Ying", "Initials": "LY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology, XiangYang Central Hospital, Xiangyang, Hubei, China (mainland)."}], "LastName": "Wei", "ForeName": "Ling-Li", "Initials": "LL"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Med Sci Monit", "NlmUniqueID": "9609063", "ISSNLinking": "1234-1010"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Glucosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Hydrolyzable Tannins"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "4Y8F71G49Q", "NameOfSubstance": "Malondialdehyde"}, {"RegistryNumber": "62LOS9TW6D", "NameOfSubstance": "corilagin"}, {"RegistryNumber": "EC 1.11.1.6", "NameOfSubstance": "Catalase"}, {"RegistryNumber": "EC 1.15.1.1", "NameOfSubstance": "Superoxide Dismutase"}, {"RegistryNumber": "EC 4.2.1.1", "NameOfSubstance": "Carbonic Anhydrases"}, {"RegistryNumber": "WM5Z385K7T", "NameOfSubstance": "Pentylenetetrazole"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Biomarkers"}, {"QualifierName": ["drug effects", "enzymology", "pathology"], "DescriptorName": "Brain"}, {"QualifierName": ["metabolism"], "DescriptorName": "Carbonic Anhydrases"}, {"QualifierName": ["metabolism"], "DescriptorName": "Catalase"}, {"QualifierName": [], "DescriptorName": "Cell Count"}, {"QualifierName": [], "DescriptorName": "Chronic Disease"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cognition"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["drug therapy", "physiopathology"], "DescriptorName": "Epilepsy"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Glucosides"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Hydrolyzable Tannins"}, {"QualifierName": ["drug effects"], "DescriptorName": "Lipid Peroxidation"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["metabolism"], "DescriptorName": "Malondialdehyde"}, {"QualifierName": ["drug effects"], "DescriptorName": "Maze Learning"}, {"QualifierName": ["drug effects"], "DescriptorName": "Mitochondrial Swelling"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Neurons"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Nissl Bodies"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": [], "DescriptorName": "Pentylenetetrazole"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["drug therapy", "physiopathology"], "DescriptorName": "Seizures"}, {"QualifierName": ["metabolism"], "DescriptorName": "Superoxide Dismutase"}], "CoiStatement": "<b>Conflict of Interest</b>. None."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Engel J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: Report of the ILAE Task Force on Classification and Terminology. Epilepsia. 2001;42(6):796\u2013803.", "ArticleIdList": ["11422340"]}, {"Citation": "Bertram EH. Temporal lobe epilepsy: Where do the seizures really begin. Epilepsy Behav. 2009;14(Suppl 1):32\u201337.", "ArticleIdList": ["PMC2913468", "18848643"]}, {"Citation": "Supuran CT. Carbonic anhydrase inhibitors: An editorial. Expert Opin Ther Pat. 2013;23(6):677\u201379.", "ArticleIdList": ["23461558"]}, {"Citation": "Aggarwal M, Kondeti B, McKenna R. Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: A patent review. Expert Opin Ther Pat. 2013;23(6):717\u201324.", "ArticleIdList": ["23514045"]}, {"Citation": "Borniquel S, Valle I, Cadenas S, et al. Nitric oxide regulates mitochondrial oxidative stress protection via the transcriptional coactivator PGC-1alpha. FASEB J. 2006;20:1889\u201391.", "ArticleIdList": ["16891621"]}, {"Citation": "Fariss MW, Chan CB, Patel M, et al. Role of mitochondria in toxic oxidative stress. Mol Interv. 2005;5:94\u2013111.", "ArticleIdList": ["15821158"]}, {"Citation": "Young C, Roth KA, Klocke BJ, et al. Role of caspase-3 in ethanol-induced developmental neurodegeneration. Neurobiol Dis. 2005;20:608\u201314.", "ArticleIdList": ["15927478"]}, {"Citation": "Schmidt OT, Lademann R. Corilagin, ein weiterer kristallisierter Gerbstoff aus Dividivi. X. Mitteilung \u00fcber nat\u00fcrliche Gerbstoffe. Justus Liebigs Annalen der Chemie. 1951;571(3):232. [in German]"}, {"Citation": "Kinoshita S, Inoue Y, Nakama S, et al. Antioxidant and hepatoprotective actions of medicinal herb, Terminalia catappa L. from Okinawa Island and its tannin corilagin. Phytomedicine. 2007;14(11):755\u201362.", "ArticleIdList": ["17293097"]}, {"Citation": "Lin TC, Hsu FL, Cheng JT. Antihypertensive activity of corilagin and chebulinic acid, tannins from Lumnitzera, racemosa. J Nat Prod. 1993;56(4):629\u201332."}, {"Citation": "Jia L, Jin H, Zhou J, et al. A potential anti-tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF-\u03b2 signaling pathways. BMC Complement Alt Med. 2013;13:33.", "ArticleIdList": ["PMC3598193", "23410205"]}, {"Citation": "Jin F, Cheng D, Tao JY, et al. Anti-inflammatory and anti-oxidative effects of corilagin in a rat model of acute cholestasis. BMC Gastroenterol. 2013;13:79.", "ArticleIdList": ["PMC3655894", "23641818"]}, {"Citation": "Zhen J, Qu Z, Fang H, et al. Effects of grape seed proanthocyanidin extract on pentylenetetrazole-induced kindling and associated cognitive impairment in rats. Int J Mol Med. 2014;34(2):391\u201398.", "ArticleIdList": ["PMC4094588", "24912930"]}, {"Citation": "Arida RM, Scorza FA, Peres CA, Cavalheiro EA. The course of untreated seizures in the pilocarpine model of epilepsy. Epilepsy Res. 1999;34(2\u20133):99\u2013107.", "ArticleIdList": ["10210024"]}, {"Citation": "Bonini JS, Da Silva WC, Bevilaqua LR, et al. On the participation of hippocampal PKC in acquisition, consolidation, and reconsolidation of spatial memory. Neuroscience. 2007;147(1):37\u201345.", "ArticleIdList": ["17499932"]}, {"Citation": "Arutla S, Arra GS, Prabhakar CM. Pro- and anti-oxidant effects of some antileprotic drugs in vitro and their influence on superoxide dismutase activity. Arzneim-Forsch J Drug Res. 1998;48:10\u201324.", "ArticleIdList": ["9825121"]}, {"Citation": "Okhawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Ann Biochem. 1979;95:351\u201358.", "ArticleIdList": ["36810"]}, {"Citation": "Beers RF, Sizer IW. Estimation of catalase. J Biol Chem. 1952;195:133\u201340.", "ArticleIdList": ["14938361"]}, {"Citation": "Ozdulger A, Cinel I, Koksel O, et al. The protective effect of N-acetylcysteine on apoptotic lung injury in cecal ligation and puncture-induced sepsis model. Shock. 2003;19:366\u201372.", "ArticleIdList": ["12688549"]}, {"Citation": "Ashkenazi SS, Perlman M. Pulmonary hypoplasia: Lung weight and radial alveolar count as criteria for diagnosis. Arch Dis Child. 1979;54:614\u201318.", "ArticleIdList": ["PMC1545796", "507916"]}, {"Citation": "He XL, Wang YH, Gao M, et al. Baicalein protects rat brain mitochondria against chronic cerebral hypoperfusion-induced oxidative damage. Brain Res. 2009;1249:212\u201321.", "ArticleIdList": ["18977207"]}, {"Citation": "Wilbur KM, Anderson NG. Electrometric and colorimetric determination of carbonic anhydrase. J Biol Chem. 1948;176:147\u201354.", "ArticleIdList": ["18886152"]}, {"Citation": "Tourov A, Ferri R, Del Gracco S, et al. Spike morphology in PTZ-induced generalized and cobalt-induced partial experimental epilepsy. Funct Neurol. 1996;11:237\u201345.", "ArticleIdList": ["9119266"]}, {"Citation": "Al-Malki AL, Sayed AA, El Rabey HA. Proanthocyanidin attenuation of oxidative stress and NF-\u03baB protects apolipoprotein E-deficient mice against diabetic nephropathy. Evid Based Complement Alternat Med. 2013;2013:769409.", "ArticleIdList": ["PMC3759251", "24023581"]}, {"Citation": "Pitkanen A, Sutula TP. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol. 2002;1:173\u201381.", "ArticleIdList": ["12849486"]}, {"Citation": "Dodrill CB. Neuropsychological effects of seizures. Epilepsy Behav. 2004;5(1):S21\u201324.", "ArticleIdList": ["14725843"]}, {"Citation": "Schroeter M, Jander S. T-cell cytokines in injury-induced neural damage and repair. Neuromolecular Med. 2005;7:183\u201395.", "ArticleIdList": ["16247179"]}, {"Citation": "Waldbaum S, Patel M. Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Res. 2010;88:23\u201345.", "ArticleIdList": ["PMC3236664", "19850449"]}, {"Citation": "Freitas RM. Investigation of oxidative stress involvement in the hippocampus in an epilepsy model induced by pilocarpine. Neurosci Lett. 2009;462:225\u201329.", "ArticleIdList": ["19616071"]}, {"Citation": "Hilvo M, Tolvanen M, Clark A, et al. Characterization of CA XV, a new GPI-anchored form of carbonic anhydrase. Biochem J. 2005;392:83\u201392.", "ArticleIdList": ["PMC1317667", "16083424"]}, {"Citation": "Chen Y, Chen C. Corilagin prevents tertbutyl hydroperoxide-induced oxidative stress injury in cultured N9 murine microglial cells. Neurochem Int. 2011;59(2):290\u201396.", "ArticleIdList": ["21683104"]}]}], "History": [{"Year": "2018", "Month": "5", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "5", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "5", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["29730669", "PMC5958630", "10.12659/MSM.906509", "906509"]}}]}